A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer. [electronic resource]
Producer: 20140113Description: 879-86 p. digitalISSN:- 1528-1140
- Adult
- Aged
- Cancer Vaccines
- Carcinoembryonic Antigen -- genetics
- Colorectal Neoplasms -- pathology
- Dendritic Cells
- Disease-Free Survival
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor
- Humans
- Immunization -- methods
- Male
- Membrane Glycoproteins
- Middle Aged
- Mucin-1 -- genetics
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- prevention & control
- Poxviridae -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.